ICCM vs. NNOX, TCMD, LUNG, CVRX, SMTI, AVR, RCEL, NVRO, ELMD, and PROF
Should you be buying IceCure Medical stock or one of its competitors? The main competitors of IceCure Medical include Nano-X Imaging (NNOX), Tactile Systems Technology (TCMD), Pulmonx (LUNG), CVRx (CVRX), Sanara MedTech (SMTI), Anteris Technologies Global (AVR), AVITA Medical (RCEL), Nevro (NVRO), Electromed (ELMD), and Profound Medical (PROF). These companies are all part of the "medical equipment" industry.
IceCure Medical vs.
IceCure Medical (NASDAQ:ICCM) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, risk, profitability, earnings, media sentiment, community ranking and analyst recommendations.
In the previous week, IceCure Medical had 12 more articles in the media than Nano-X Imaging. MarketBeat recorded 15 mentions for IceCure Medical and 3 mentions for Nano-X Imaging. Nano-X Imaging's average media sentiment score of 0.63 beat IceCure Medical's score of 0.09 indicating that Nano-X Imaging is being referred to more favorably in the news media.
IceCure Medical has a net margin of -376.85% compared to Nano-X Imaging's net margin of -465.38%. Nano-X Imaging's return on equity of -27.63% beat IceCure Medical's return on equity.
Nano-X Imaging received 5 more outperform votes than IceCure Medical when rated by MarketBeat users. However, 96.30% of users gave IceCure Medical an outperform vote while only 72.09% of users gave Nano-X Imaging an outperform vote.
IceCure Medical has higher earnings, but lower revenue than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks.
IceCure Medical currently has a consensus price target of $2.50, indicating a potential upside of 130.63%. Nano-X Imaging has a consensus price target of $17.50, indicating a potential upside of 235.57%. Given Nano-X Imaging's higher probable upside, analysts plainly believe Nano-X Imaging is more favorable than IceCure Medical.
0.6% of IceCure Medical shares are held by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are held by institutional investors. 2.4% of IceCure Medical shares are held by insiders. Comparatively, 7.7% of Nano-X Imaging shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
IceCure Medical has a beta of 0.37, indicating that its stock price is 63% less volatile than the S&P 500. Comparatively, Nano-X Imaging has a beta of 1.99, indicating that its stock price is 99% more volatile than the S&P 500.
Summary
Nano-X Imaging beats IceCure Medical on 11 of the 19 factors compared between the two stocks.
Get IceCure Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for ICCM and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
IceCure Medical Competitors List
Related Companies and Tools
This page (NASDAQ:ICCM) was last updated on 3/28/2025 by MarketBeat.com Staff
Buy ICCM Stock Free ICCM Stock Alerts